Otezla
Generic name: Apremilast
Dosage form: tablet
Drug class:
Antirheumatics
Usage of Otezla
Otezla (apremilast) is a tablet taken twice a day that is used to lower inflammation in the treatment of specific types of psoriatic arthritis, plaque psoriasis and Behçet's disease.
Otezla works by inhibiting an enzyme within your immune system that can affect certain cells and contribute to inflammation in the body.
Otezla is from a group of medicines called PDE4 inhibitors (Phosphodiesterase-4 inhibitors) that lower inflammation by increasing the level of cAMP (cyclic adenosine monophosphate) which is a messenger system in our bodies. Otezla is not a biologic agent.
Otezla received FDA approval on March 21, 2014, for psoriatic arthritis and since then it has also been FDA approved for the treatment of types of plaque psoriasis and Behcet’s disease.
Otezla side effects
Get emergency medical help if you have signs of an allergic reaction to this medicine: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Otezla may cause serious side effects. Call your doctor at once if you have:
Common Otezla side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Otezla
You should not use apremilast if you are allergic to it.
To make sure this medicine is safe for you, tell your doctor if you have ever had:
This medicine is not approved for use by anyone younger than 18 years old.
Pregnancy:
Otezla may harm an unborn baby. It is important to use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of apremilast on the baby.
Breastfeeding:
It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.
Relate drugs
- Apremilast
- Auranofin
- Cuprimine
- Depen
- D-Penamine
- Otezla
- Penicillamine
- Ridaura
- Rinvoq
- Tofacitinib
- Upadacitinib
- Xeljanz
How to use Otezla
Usual Adult Dose for Psoriatic Arthritis, Plaque Psoriasis and Behcet’s disease
Otezla usually begins at a low dose that is increased over 5 days to the maintenance dose, this is to reduce gastrointestinal symptoms that may happen when you first start taking this medicine. You may be given your medicine in a starter pack containing tablets that are different strengths, it is important to follow your doctor's instructions carefully.
Starting dose:
Day 1: 10 mg orally once a day (AM)
Day 2: 10 mg orally twice a day (AM and PM)
Day 3: 10 mg orally once a day (AM); 20 mg orally once a day (PM)
Day 4: 20 mg orally twice a day (AM and PM)
Day 5: 20 mg orally once a day (AM); 30 mg orally once a day (PM)
Maintenance dose:
30 mg orally twice a day (AM and PM)
Keep track of your body weight while you are taking this medicine, and tell your doctor about any major weight loss.
Warnings
Some people have thoughts about suicide while taking this medicine. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.
What other drugs will affect Otezla
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even though there may be an interaction. In these situations, your doctor may want to change the dose, or other precautions may be necessary. When you are taking Oztela it is important to tell your doctor about all your current medicines and any medicine you start or stop using. It is especially important that your healthcare professional knows if you are taking any of the medications in the list below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using Otezla with any of the following medicines may not be recommended, but may be necessary in some cases. If both medicines are to be used together, your doctor may change the dose or how often you use one or both of the medicines.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions